Press Release


Owkin Receives European Medicines Agency Letter of Support for Innovative AI-Driven Approach to Oncology Trial Analysis
May 17, 2023 06:00 JST
AI Biotech Owkin, a leading provider of AI-powered solutions for drug discovery and clinical development, has received a letter of support from the European Medicines Agency (EMA) regarding their proposed statistical adjustment on deep learning prognosis covariates obtained from histological slides.
More info..

Latest Release


More Latest Release >>